(secondQuint)A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer.

 The primary objective of this study is to compare the consumption, in milligrams, of rescue analgesia (normal release morphine sulfate tablets) after the administration of sufentanil TDS or sustained release morphine sulfate.

 The secondary efficacy objectives of this study are to evaluate: - Pharmacokinetic data - Adverse events.

 A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer@highlight

The study hypothesis is that the safety and efficacy of sufentanil following transdermal application is comparable to sustained release morphine sulphate tablets in patients with chronic pain due to cancer.

